PMF Cancer 2019 Speakers
Dr Eric O. Aboagye, PhD FMedSci
Dr Eric Aboagye holds the position of Professor of Cancer Pharmacology and Molecular Imaging at Imperial College London....
Prof Sibylle Mittnacht
Sibylle Mittnacht, Professor of Cell and Molecular Oncology, University College London (UCL) Cancer Institute....
Dr Jutta Heix
Dr Jutta Heix Head of International Affairs at Oslo Cancer Cluster, is a life science professional with more than 20 years of industry experience....
Prof. Lars Bullinger
Lars Bullinger holds a full professorship for “Hematology and Oncology” and is the Medical Director of the Department of Hematology, Oncology and Tumorimmunology....
Christian Ruiz, PhD, MBA
Christian Ruiz, PhD, MBA, Head Diagnostic Laboratory Department, Co-Director Research Department Path., Med. Genetics & Pathology, University Hospital Basel...
Denis Lacombe Director General
Dr Lacombe is the author of well over 104 peer reviewed publications and communications that have had a positive impact on the future of cancer therapy....
Prof. Dr. med Ulrich Keilholz
Prof. Dr. med Ulrich Keilholz, Charité Comprehensive Cancer Center ...
Prof. Klaus Cichutek, PhD
Klaus Cichutek, President of the Paul-Ehrlich-Institut, Federal Institute for Vaccines & Biomedicines, Germany, Professor of Biochemistry, Goethe University...
Prof. Nisar Malek
Prof. Nisar Malek, Director of the Center for Personalized Medicine, University of Tübingen and MD, Dept. of Internal Medicine, University Hospital Tübingen...
Dr. Benedikt Westphalen
Dr. Benedikt Westphalen, Head of Molecular Diagnostics and Therapy Program and the Molecular Tumour Board, Comprehensive Cancer Centre, University Munich, Germany....
Prof. Stefan Fröhling
Prof. Stefan Fröhling heads the Division of Translational Medical Oncology at DKFZ and is Acting Managing Director of NCT Heidelberg....
Joshua Armenia
Joshua Armenia is a Senior Scientist at AstraZeneca where he works in the Oncology Bioinformatics group and his main focus is the DNA damage response portfolio...
Leticia De Mattos-Arruda, MD PhD
Leticia De Mattos-Arruda is a medical oncologist, clinician-scientist and group leader at the IrsiCaixa Foundation, Barcelona, Spain....
Dr Bettina Ryll
Dr Bettina Ryll is the Founder of the Melanoma Patient Network Europe and, until December 2018, Chair of the ESMO Patient Advocates Working Group (PAWG)....
Maud Kamal, PhD
Maud Kamal, PhD is the scientific manager of the department of Drug Development and Innovation at Institut Curie....
Prof Maarten J Postma
Holds the chair Global Health Economics at the University Medical Center Groningen (UMCG) and the faculty of Economics & Business...
Prof. Andrew V. Biankin
Professor Andrew Biankin is the Regius Professor of Surgery at the University of Glasgow, a Cancer Research UK Clinician Scientist, a Wellcome Trust Senior Investigator, a Fellow of the Royal Society of Edinburgh and the Academy of...
Dr. Andreas Penk
Andreas joined Pfizer in 1994 and, after holding leading positions in the organization at both the country and regional levels, currently serves as the Oncology Regional President for International Developed Markets....
Ulrik Lassen, Professor, MD, Ph.D
Ulrik Lassen, Professor, MD, Ph.D., is specialised in internal medicine and medical oncology. He graduated from the University of Copenhagen in 1991 and started training in medical oncology in 1992....
Prof. Kjetil Taskén
Prof. Kjetil Taskén received his M.D. in 1991 and did his Ph.D. in molecular and cell biology (1994) at the University of Oslo (UiO)....
“…an inspiring and interesting forum. It is the must attend conference for precision medicine in the region.”Eurofins